lamotrigine 150 MG Oral Tablet [Subvenite]
- RxCUI
- 2001506
- RxNorm name
- lamotrigine 150 MG Oral Tablet [Subvenite]
- Display name
- lamotrigine 150 MG Oral Tablet [Subvenite]
- Full name
- lamotrigine 150 MG Oral Tablet [Subvenite]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SUBVENITE | LAMOTRIGINE | OWP Pharmaceuticals, Inc. | 7ad18b68-ba16-4810-9c3e-27fa970454e8 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 2001506 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7ad18b68-ba16-4810-9c3e-27fa970454e8 | lamotrigine 150 MG Oral Tablet [Subvenite] | SBD | 15 | These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets, for oral use Initial U.S. Approval: 1994 | 20260327 |
| 7ad18b68-ba16-4810-9c3e-27fa970454e8 | Subvenite 150 MG Oral Tablet | SY | 15 | These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets, for oral use Initial U.S. Approval: 1994 | 20260327 |
| 7ad18b68-ba16-4810-9c3e-27fa970454e8 | Subvenite 150 MG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets, for oral use Initial U.S. Approval: 1994 | 20260327 |